Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years
- Christopher Troeger
- Ibrahim A. Khalil
- Puja C Rao
- Shujin Cao
- Brigette F. Blacker
- TATahmeed Ahmed
- George Armah
- Julie E. Bines
- Thomas G. Brewer
- Danny V. Colombara
- Gagandeep Kang
- Beth D. Kirkpatrick
- Carl D. Kirkwood
- Jason M. Mwenda
- Umesh D. Parashar
- William A. Petri
- Mark S. Riddle
- A. Duncan Steele
- Robert L. Thompson
- Judd L. Walson
- John W. Sanders
- Ali H. Mokdad
- Christopher J L Murray
- Simon I Hay
- Robert C. Reiner
- TATahmeed Ahmed
Archives of Pediatrics and Adolescent Medicine · 2018 · American Medical Association
6 views · 0 downloads
Abstract
Importance: Rotavirus infection is the global leading cause of diarrhea-associated morbidity and mortality among children younger than 5 years. Objectives: To examine the extent of rotavirus infection among children younger than 5 years by country and the number of deaths averted because of the rotavirus vaccine. Design, Setting, and Participants: This report builds on findings from the Global Burden of Disease Study 2016, a cross-sectional study that measured diarrheal diseases and their etiologic agents. Models were used to estimate burden in data-sparse locations. Exposure: Diarrhea due to rotavirus infection. Main Outcomes and Measures: Rotavirus-associated mortality and morbidity by country and year and averted deaths attributable to the rotavirus vaccine by country. Results: Rotavirus infection was responsible for an estimated 128 500 deaths (95% uncertainty interval [UI], 104 500-155 600) among children younger than 5 years throughout the world in 2016, with 104 733 deaths occurring in sub-Saharan Africa (95% UI, 83 406-128 842). Rotavirus infection was responsible for more than 258 million episodes of diarrhea among children younger than 5 years in 2016 (95% UI, 193 million to 341 million), an incidence of 0.42 cases per child-year (95% UI, 0.30-0.53). Vaccine use is estimated to have averted more than 28 000 deaths (95% UI, 14 600-46 700) among children younger than 5 years, and expanded use of the rotavirus vaccine, particularly in sub-Saharan Africa, could have prevented approximately 20% of all deaths attributable to diarrhea among children younger than 5 years. Conclusions and Relevance: Rotavirus-associated mortality has decreased markedly over time in part because of the introduction of the rotavirus vaccine. This study suggests that prioritizing vaccine introduction and interventions to reduce diarrhea-associated morbidity and mortality is necessary in the continued global reduction of rotavirus infection.
